Details for Patent: 9,119,554

Which drugs does patent 9,119,554 protect, and when does it expire?

Patent 9,119,554 protects ABILIFY MYCITE KIT and is included in one NDA.

This patent has one hundred and twenty-five patent family members in twenty-two countries.

Summary for Patent: 9,119,554

Title:	Pharma-informatics system
Abstract:	Compositions, systems and methods that allow for the detection of the actual physical delivery of a pharmaceutical agent to a body are provided. Embodiments of the compositions include an identifier and an active agent. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
Inventor(s):	Zdeblick; Mark (Portola Valley, CA), Pikelny; Aleksandr (Los Angeles, CA), Robertson; Timothy (Belmont, CA), Hafezi; Hooman (Redwood City, CA)
Assignee:	Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:	12/949,720
Patent Claim Types: see list of patent claims	Use; Composition; Device;

Drugs Protected by US Patent 9,119,554

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-001	Nov 13, 2017		RX	Yes	No			Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-002	Nov 13, 2017		RX	Yes	Yes			Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-003	Nov 13, 2017		RX	Yes	No			Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-004	Nov 13, 2017		RX	Yes	No			Y
Otsuka	ABILIFY MYCITE KIT	aripiprazole	TABLET;ORAL	207202-005	Nov 13, 2017		RX	Yes	No			Y

International Family Members for US Patent 9,119,554

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006239221
Australia	2012282690
Australia	2012282772
Australia	2012282776
Australia	2012282777